Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: South Korea

Dongbu Bio-Health Care Securities Investment Trust 1 - Equity

+ Add to Watchlist

6170104:KS

1,319.35 KRW 0.000.00%

As of 20:08:41 ET on 05/27/2015.

Snapshot for Dongbu Bio-Health Care Securities Investment Trust 1 - Equity (6170104)

Year To Date: +40.16% 3-Month: +19.86% 3-Year: +24.58% 52-Week Range: 912.26 - 1,342.41
1-Month: +9.08% 1-Year: +44.46% 5-Year: +15.72% Beta vs KOSPI: 0.70

Mutual Fund Chart for 6170104

No chart data available.
  • 6170104:KS 1,319.35
  • 1M
  • 1Y
Interactive 6170104 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 6170104

Dongbu Bio-Health Care Securities Investment Trust 1 (Equity) is an open-end fund incorporated in South Korea. The Fund's objective is to achieve capital gains and current income. The Fund invests at least 50% of its total assets in Bio-Health Care stocks.

Inception Date: 11-03-2009 Telephone: 82-2-787-3700
Managers: YONG-NAM HAN
Web Site: www.dongbuam.co.kr

Fundamentals for 6170104

NAV (on 2015-05-28) 1,319.35
Assets (M) (on 2015-05-27) 175,833.95
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for 6170104

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-11-03) 103.96
Dividend Yield (ttm) 7.88

Fees & Expenses for 6170104

Front Load -
Back Load -
Current Mgmt Fee 0.72
Redemption Fee -
12b1 Fee -
Expense Ratio 1.29

Top Fund Holdings for 6170104

Filing Date: 01/31/2015
Name Position Value % of Total
HLB Inc 136,088 1,381,293,200 0.000%
Naturalendo Tech Co Ltd 18,542 964,184,000 0.000%
InBody Co Ltd 23,032 893,641,600 0.000%
Chong Kun Dang Pharmaceutical 14,270 799,120,000 0.000%
JVM Co Ltd 13,122 776,822,400 0.000%
CTC BIO Inc 41,687 739,944,250 0.000%
Vieworks Co Ltd 21,847 717,673,950 0.000%
Huvitz Co Ltd 43,322 708,314,700 0.000%
Chongkundang Holdings Corp 10,344 612,364,800 0.000%
Chabiotech Co Ltd 38,406 545,365,200 0.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil